A Phase I Study of FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Patidegib (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Adverse reactions
- 30 Dec 2014 Planned End Date changed from 1 Dec 2013 to 1 Nov 2018 as reported by ClinicalTrials.gov.
- 30 Dec 2014 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 04 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.